Pathogen Genomics Diagnostics Market is expected to reach USD 11.2 billion by 2031

Pathogen Genomics Diagnostics Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the pathogen genomics diagnostics market will expand from USD 6.1 billion in 2026 to USD 11.2 billion in 2031 at a CAGR of 12.9% during the forecast period.

Genomic technologies are being integrated into diagnostics and public health monitoring of infectious diseases, and this is driving rapid growth in the market. Pathogen genomics diagnostics are advancing our understanding of disease detection, surveillance, and pathogen identification and characterization, a process that can be done quickly and across healthcare and research environment. Advances in PCR, next-generation sequencing (NGS), whole genome sequencing, and metagenomic sequencing are improving diagnostics, outbreak investigations, and AMR analysis. Moreover, the increasing demand for real-time epidemiological surveillance, growing incidence of emerging infectious diseases, and increasing government initiatives for pandemic preparedness are helping to make pathogen genomics diagnostic solutions a common phenomenon in the world.

Request a free sample copy or view the report summary: Pathogen Genomics Diagnostics Market Report

Pathogen Genomics Diagnostics Market Report Highlights

• Kits & Reagents segment is expected to hold a major market share because of the high level of their usage in genomic testing workflows, pathogen detection, and sequencing applications. Though, substantial growth is being seen in instruments with the growing usage of advanced sequencing and PCR platforms in laboratories and healthcare institutions. Software & services are also showing growth as an increasing need for genomic data analysis, bioinformatics solutions, and cloud-based pathogen surveillance platforms grow.

• By technology, polymerase chain reaction (PCR) is the leading technology due to its broad application in rapid and sensitive detection of pathogens. Next-generation sequencing (NGS) is growing in importance because of its ability to deliver detailed information about the genome and to facilitate pathogen surveillance at a large scale. Whole genome sequencing is becoming more popular for the identification of strains, outbreak investigations, and resistance analysis; metagenomic sequencing has been gaining traction because of its ability to identify a range of different pathogens directly from clinical samples without the need for prior culture.

• Infectious disease diagnosis is a significant market share of the disease diagnosis market owing to the rising need for pathogen identification, which takes place quickly and accurately. Epidemiological surveillance is expanding greatly due to efforts by public health groups to expand its coverage and to the need for timely detection of the spread of infectious disease. The growing emphasis on pandemic preparedness and genomic surveillance of novel pathogens is driving the growth of outbreak investigation applications, and detection of antimicrobial resistance is a vital area as global concerns about drug-resistant infections continue to grow.

• By Geography, North America is the largest pathogen genomics diagnostics market, attributable to the presence of the advanced healthcare facilities, well-developed genomic research abilities, high level of government funding, and wide spread adoption of sequencing technologies. Investments in public health surveillance and supportive regulatory environments, and the growing interest in infectious disease management, are contributing to significant growth in Europe. Expansion of healthcare infrastructure, increasing prevalence of infectious diseases, the adoption of genomic technologies, and rising government initiatives for precision medicine and pathogen surveillance in countries like China, India, Japan and South Korea, are expected to drive the growth in Asia-Pacific.

Pathogen Genomics Diagnostics Market Growth Drivers and Restraints

Growth Drivers:

• Increasing Demand for Infectious Disease Surveillance and Outbreak Monitoring: Growing prevalence of infectious diseases and an increased interest in pandemic preparedness are driving the use of pathogen genomics diagnostics for fast detection and monitoring.

• Advancements in Genomic Sequencing Technologies: Ongoing innovations in PCR, NGS, whole genome sequencing and bioinformatics, are advancing the diagnostic speed, accuracy, and scalability, thus driving market growth.

Restraints:

• High Cost of Advanced Genomic Technologies: Advanced genomic technologies are costly, which could hinder their use in resource-poor environments.

• Data Management and Regulatory Challenges: Storage, interpretation, standardization, and regulatory aspects can be complicated for genomic data, thereby causing problems in the general adoption of pathogen genomics diagnostic solutions.

Pathogen Genomics Diagnostics Market Key Development

• Product Launch: In November 2025, Thermo Fisher Scientific announced that its EXENT Analyser and Immunoglobulin Isotypes (GAM) Assay received 510(k) clearance from the U.S. Food and Drug Administration as an automated molecular diagnostic platform designed to assist in the detection and identification of multiple myeloma and related plasma cell disorders.

Pathogen Genomics Diagnostics Market Segmentation

Knowledge Sourcing Intelligence has segmented the pathogen genomics diagnostics by product type, technology, application, and geography:

Pathogen Genomics Diagnostics Market By Product Type

• Instruments

• Kits & Reagents

• Software & Services

Pathogen Genomics Diagnostics Market By Technology

• Polymerase Chain Reaction (PCR)

• Next-Generation Sequencing (NGS)

• Whole Genome Sequencing

• Metagenomic Sequencing

Pathogen Genomics Diagnostics Market By Application

• Outbreak Investigation

• Antimicrobial Resistance Detection

• Epidemiological Surveillance

• Infectious Disease Diagnosis

Pathogen Genomics Diagnostics Market By Region

• North America

  • USA

  • Canada

  • Mexico

• South America

  • Brazil

  • Argentina

  • Others

• Europe

  • United Kingdom

  • Germany

  • France

  • Spain

  • Others

• Middle East and Africa

  • Saudi Arabia

  • UAE

  • Others

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Indonesia

  • Thailand

  • Others

Pathogen Genomics Diagnostics Market Key Players

• Illumina

• Thermo Fisher Scientific

• Roche Diagnostics

• QIAGEN

• Agilent Technologies

• Bio-Rad Laboratories

• Danaher Corporation

• BGI Genomics

• Oxford Nanopore Technologies

• Pacific Biosciences